like ivermectin. This suggests that horses with such endocrine disorders might be more prone to parasitic infections.
In a study conducted by Martin Nielsen and colleagues at the University of Kentucky, the response to ivermectin was evaluated in horses with insulin dysregulation (ID), pituitary pars intermedia dysfunction (PPID), or neither condition.
The study population was part of a special herd at the University of Kentucky’s Department of Veterinary Science, which included horses with and without these endocrine disorders. These horses were kept in permanent paddocks without pasture rotation or enhanced hygiene practices and received routine anthelmintic treatments: ivermectin in March or April and July or August, and moxidectin/praziquantel in November.
The study focused on senior horses (aged 13 years and over) and those with or without PPID, ID, or both. Out of 47 horses in the research herd, 19 met the criteria for inclusion. These horses, all with positive faecal worm egg counts, were treated with ivermectin at the recommended dose of 200 mcg/kg. Faecal samples were collected before treatment, two weeks post-treatment (for the Faecal Egg Count Reduction Test, or FECRT), and then weekly until worm eggs reappeared in the faeces (Egg Reappearance Period, or ERP).
Two laboratory tests were employed to assess the response to ivermectin: the Faecal Egg Count Reduction Test (FECRT) and the Egg Reappearance Period (ERP). For the FECRT, a reduction of at least 99.7% in worm egg counts is considered effective two weeks post-treatment. The ERP for ivermectin is typically 8-10 weeks.
The study found no significant differences in the effectiveness of ivermectin between the groups. However, the small sample size may have made it difficult to detect any potential differences. Overall, ivermectin was highly effective, with all horses showing a greater than 99.7% reduction in worm egg counts at the two-week mark.
Nonetheless, the researchers observed that the ERP was shorter in horses with ID and those with both PPID and ID, at six and seven weeks respectively, compared to eight weeks for both the PPID-only and healthy control groups.
They suggest that their findings indicate a need for further investigation of the possible influence of endocrine disorders on anthelmintic performance in horses.
For more details, see:
M.K. Nielsen, C.A. Finnerty, N.E. Ripley, A.E. Page, M.E. McClendon, A.A. Adams,
Ivermectin performance in horses diagnosed with equine endocrine disorders,
Veterinary Parasitology, (2024) Vol 328,110182,
No comments:
Post a Comment